Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

This publication has 22 references indexed in Scilit:

• Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
  New England Journal of Medicine, 1999
• Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome
  New England Journal of Medicine, 1998
• Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
  Fertility and Sterility, 1998
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
  Obstetrics & Gynecology, 1997
• Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
  New England Journal of Medicine, 1996
• Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
  Journal of Clinical Investigation, 1995
• Effects of Insulin-Like Growth Factors I and II and Insulin on the Immortalized Hypothalamic GTI-7 Cell Line
  Neuroendocrinology, 1995
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
  Metabolism, 1994
• Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?
  American Journal of Obstetrics and Gynecology, 1992
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance
  Diabetes, 1979